A systematic review of repetitive transcranial magnetic stimulation in aphasia rehabilitation: Leads for future studies.


Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
08 2021
Historique:
received: 12 01 2021
revised: 01 04 2021
accepted: 09 04 2021
pubmed: 17 4 2021
medline: 4 8 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive tool that induces neuromodulation in the brain. Several studies have shown that rTMS improves language recovery in patients with post-stroke aphasia. This systematic review summarizes the role of rTMS in aphasia rehabilitation. We searched MEDLINE via PubMed and Scopus on 30October, 2020, for English articles (1996-2020). Eligible studies involved post-stroke aphasia rehabilitation with rTMS. In some of these studies, rTMS was also combined with speech therapy. In total, seven meta-analyses and 59studies (23randomized clinical trials) were included in this systematic review. The methods used in these studies were heterogeneous. Only six studies did not find that rTMS had a significant effect on language performance. The evidence from the peer-reviewed literature suggests that rTMS is an effective tool in post-stroke aphasia rehabilitation. However, the precise mechanisms that underlie the effects of rTMS and the reorganization of language networks in patients who have had a stroke remain unclear. We discuss these crucial challenges in the context of future studies.

Sections du résumé

BACKGROUND
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive tool that induces neuromodulation in the brain. Several studies have shown that rTMS improves language recovery in patients with post-stroke aphasia.
OBJECTIVE
This systematic review summarizes the role of rTMS in aphasia rehabilitation.
METHODS
We searched MEDLINE via PubMed and Scopus on 30October, 2020, for English articles (1996-2020). Eligible studies involved post-stroke aphasia rehabilitation with rTMS. In some of these studies, rTMS was also combined with speech therapy.
RESULTS
In total, seven meta-analyses and 59studies (23randomized clinical trials) were included in this systematic review. The methods used in these studies were heterogeneous. Only six studies did not find that rTMS had a significant effect on language performance.
CONCLUSIONS
The evidence from the peer-reviewed literature suggests that rTMS is an effective tool in post-stroke aphasia rehabilitation. However, the precise mechanisms that underlie the effects of rTMS and the reorganization of language networks in patients who have had a stroke remain unclear. We discuss these crucial challenges in the context of future studies.

Identifiants

pubmed: 33862065
pii: S0149-7634(21)00160-3
doi: 10.1016/j.neubiorev.2021.04.008
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

212-241

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Sophie Arheix-Parras (S)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Institut Universitaire des Sciences de la Réadaptation, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France.

Charline Barrios (C)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Institut Universitaire des Sciences de la Réadaptation, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France.

Grégoire Python (G)

Faculté de psychologie, Université de Genève, Geneva, Switzerland.

Mélanie Cogné (M)

Department of Physical Medicine and Rehabilitation, CHU de Rennes, Rennes, France.

Igor Sibon (I)

INCIA, CNRS, UMR5287, University of Bordeaux, F-33400, Talence, France; Stroke Unit, Clinical Neurosciences Department, CHU de Bordeaux, 33076, Bordeaux, France.

Mélanie Engelhardt (M)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Institut Universitaire des Sciences de la Réadaptation, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France.

Patrick Dehail (P)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Institut Universitaire des Sciences de la Réadaptation, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France.

Hélène Cassoudesalle (H)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France.

Geoffroy Moucheboeuf (G)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France.

Bertrand Glize (B)

Handicap Activité Cognition Santé, BPH U1219 Inserm, Université de Bordeaux, F-33000, Bordeaux, France; Institut Universitaire des Sciences de la Réadaptation, Université de Bordeaux, F-33000, Bordeaux, France; Department of physical medicine and rehabilitation, CHU de Bordeaux, F-33000, Bordeaux, France; Faculté de psychologie, Université de Genève, Geneva, Switzerland; Institute of Neurodegenerative Diseases, CNRS UMR 5293, Université de Bordeaux, F-33000, Bordeaux, France. Electronic address: bertrand.glize@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH